Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjing Zou

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinomaMinjing Zou, Konrad S Famulski, Ranjit S Parhar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2006
Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse modelYufei Shi, Minjing Zou, Katharine Collison, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1Ali S Alzahrani, Minjing Zou, Essa Y Baitei, et al.
Endocrine|May 24, 2011
Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutationsMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
The Journal of Pathology|January 22, 2009
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinomaEssa Y Baitei, Minjing Zou, Futwan Al-Mohanna, et al.
Clinical Endocrinology|January 3, 2014
Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinomaMinjing Zou, Faisal S BinHumaid, Ali S Alzahrani, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2015
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse modelRanjit S Parhar, Minjing Zou, Futwan A Al-Mohanna, et al.
Human Gene Therapy|December 13, 2003
Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion proteinYufei Shi, Ranjit S Parhar, Minjing Zou, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2021
Insights of Noncanonical Splice-site Variants on RNA Splicing in Patients With Congenital HypothyroidismNajla Albader, Minjing Zou, Huda A BinEssa, et al.
Bone|October 20, 2012
Novel and de novo PHEX mutations in patients with hypophosphatemic ricketsErdem Durmaz, Minjing Zou, Roua A Al-Rijjal, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinomaMinjing Zou, Konrad S Famulski, Ranjit S Parhar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2006
Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse modelYufei Shi, Minjing Zou, Katharine Collison, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1Ali S Alzahrani, Minjing Zou, Essa Y Baitei, et al.
Endocrine|May 24, 2011
Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutationsMinjing Zou, Essa Y Baitei, Ali S Alzahrani, et al.
The Journal of Pathology|January 22, 2009
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinomaEssa Y Baitei, Minjing Zou, Futwan Al-Mohanna, et al.
Clinical Endocrinology|January 3, 2014
Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinomaMinjing Zou, Faisal S BinHumaid, Ali S Alzahrani, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2015
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse modelRanjit S Parhar, Minjing Zou, Futwan A Al-Mohanna, et al.
Human Gene Therapy|December 13, 2003
Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion proteinYufei Shi, Ranjit S Parhar, Minjing Zou, et al.
The Journal of Clinical Endocrinology and Metabolism|October 11, 2021
Insights of Noncanonical Splice-site Variants on RNA Splicing in Patients With Congenital HypothyroidismNajla Albader, Minjing Zou, Huda A BinEssa, et al.
Bone|October 20, 2012
Novel and de novo PHEX mutations in patients with hypophosphatemic ricketsErdem Durmaz, Minjing Zou, Roua A Al-Rijjal, et al.
Pageof 4